EPPIN
gene geneOn this page
Also known as EPPIN1EPPIN2EPPIN3dJ461P17.2WAP7WFDC7CT71
Summary
EPPIN (epididymal peptidase inhibitor, HGNC:15932) is a protein-coding gene on chromosome 20q13.12, encoding Eppin (O95925). Serine protease inhibitor that plays an essential role in male reproduction and fertility.
This gene encodes an epididymal protease inhibitor, which contains both kunitz-type and WAP-type four-disulfide core (WFDC) protease inhibitor consensus sequences. Most WFDC genes are localized to chromosome 20q12-q13 in two clusters: centromeric and telomeric. This gene is a member of the WFDC gene family and belongs to the telomeric cluster. The protein can inhibit human sperm motility and exhibits antimicrobial activity against E. coli, and polymorphisms in this gene are associated with male infertility. Read-through transcription also exists between this gene and the downstream WFDC6 (WAP four-disulfide core domain 6) gene. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 57119 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_020398
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15932 |
| Approved symbol | EPPIN |
| Name | epididymal peptidase inhibitor |
| Location | 20q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | EPPIN1, EPPIN2, EPPIN3, dJ461P17.2, WAP7, WFDC7, CT71 |
| Ensembl gene | ENSG00000101448 |
| Ensembl biotype | protein_coding |
| OMIM | 609031 |
| Entrez | 57119 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000336443, ENST00000354280, ENST00000409554, ENST00000496898
RefSeq mRNA: 2 — MANE Select: NM_020398
NM_001302861, NM_020398
CCDS: CCDS13359
Canonical transcript exons
ENST00000354280 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001290879 | 45540626 | 45542154 |
| ENSE00001885325 | 45547267 | 45547401 |
| ENSE00003560863 | 45542700 | 45542867 |
| ENSE00003676714 | 45545639 | 45545770 |
Expression profiles
Bgee: expression breadth broad, 96 present calls, max score 96.98.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0115 / max 8.8046, expressed in 3 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 187452 | 0.2667 | 5 |
| 187453 | 0.0203 | 4 |
| 187455 | 0.0073 | 3 |
| 187456 | 0.0042 | 2 |
Top tissues by expression
218 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right testis | UBERON:0004534 | 96.98 | gold quality |
| corpus epididymis | UBERON:0004359 | 96.22 | gold quality |
| left testis | UBERON:0004533 | 96.04 | gold quality |
| buccal mucosa cell | CL:0002336 | 94.32 | gold quality |
| testis | UBERON:0000473 | 93.50 | gold quality |
| adult organism | UBERON:0007023 | 93.44 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 85.43 | gold quality |
| bronchus | UBERON:0002185 | 84.28 | gold quality |
| bronchial epithelial cell | CL:0002328 | 83.95 | gold quality |
| cauda epididymis | UBERON:0004360 | 82.19 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 81.84 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 80.63 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.20 | silver quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.91 | gold quality |
| right uterine tube | UBERON:0001302 | 77.32 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 73.79 | gold quality |
| caput epididymis | UBERON:0004358 | 68.97 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 66.50 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 65.77 | silver quality |
| male germ cell | CL:0000015 | 63.17 | silver quality |
| sperm | CL:0000019 | 59.78 | silver quality |
| oviduct epithelium | UBERON:0004804 | 57.78 | silver quality |
| upper leg skin | UBERON:0004262 | 57.36 | gold quality |
| fallopian tube | UBERON:0003889 | 56.90 | gold quality |
| tibialis anterior | UBERON:0001385 | 56.77 | silver quality |
| ileal mucosa | UBERON:0000331 | 56.36 | silver quality |
| left lobe of thyroid gland | UBERON:0001120 | 55.16 | gold quality |
| right lung | UBERON:0002167 | 54.88 | gold quality |
| cranial nerve II | UBERON:0000941 | 54.73 | gold quality |
| thyroid gland | UBERON:0002046 | 53.72 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 487.60 |
| E-ANND-3 | yes | 9.08 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): ATRX, ESR1
miRNA regulators (miRDB)
31 targeting EPPIN, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3134 | 100.00 | 66.43 | 777 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-LET-7D-5P | 99.96 | 71.76 | 1632 |
| HSA-MIR-4458 | 99.96 | 71.64 | 1650 |
| HSA-MIR-1825 | 99.72 | 68.11 | 1089 |
| HSA-MIR-875-3P | 99.63 | 69.47 | 2548 |
| HSA-MIR-671-5P | 99.52 | 67.11 | 1277 |
| HSA-MIR-766-5P | 99.47 | 67.91 | 2225 |
| HSA-MIR-4426 | 99.17 | 66.74 | 1949 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-4738-3P | 98.98 | 67.98 | 1846 |
| HSA-MIR-10526-3P | 97.86 | 64.97 | 1342 |
| HSA-MIR-4314 | 97.50 | 67.30 | 1369 |
| HSA-MIR-3192-5P | 96.98 | 65.76 | 1926 |
| HSA-MIR-1270 | 96.94 | 66.65 | 931 |
| HSA-MIR-620 | 96.94 | 66.79 | 888 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-1236-5P | 96.62 | 66.38 | 856 |
| HSA-MIR-5586-3P | 95.51 | 67.00 | 805 |
Literature-anchored findings (GeneRIF, showing 14)
- This antimicrobial peptide permeabilized outer and inner membranes of E. coli, consistent with its ability to induce striking morphological alterations of E. coli membranes. Has role in innate immune system of human epididymis. (PMID:15229136)
- in seminal plasma and on spermatozoa following ejaculation, Eppin is bound to semenogelin I (PMID:15590901)
- although both of eppin’s domains are involved in the protein’s antibacterial activity, only the Kunitz domain is required for selective protease inhibition (PMID:18331357)
- Eppin protects a 15-kDa fragment of semenogelin from hydrolysis by prostate specific antigen (PMID:18645681)
- Eppin can modulate intracellular calcium concentrations and subsequently affect the calcium ionophore A23187-induced acrosome reaction. (PMID:19801569)
- Cysteine 239 of rSEMG1 appears to be the critical amino acid for both binding to eppin and inhibiting sperm motility. (PMID:19889947)
- Genetic variants in the Eppin gene may be associated with semen quality. (PMID:20158997)
- Different variants in the EPPIN gene are related to idiopathic male infertility and men carrying these variants have a decreased or increased risk of abnormal semen parameters associated with male infertility. (PMID:20488803)
- Letter: Eppin overexpression in prostate cancer correlates with favorable prognosis. (PMID:21392882)
- The expression of mouse EPPIN protein was detected in A1-A4 spermatogonia and the expression of human EPPIN was detected in type A spermatogonia as well as in the earliest preleptotene spermatocytes. (PMID:21461566)
- EPPIN’s semenogelin I binding site: a contraceptive drug target. (PMID:22699487)
- EPPIN and SEMG1 rapidly co-evolved in primates (PMID:24312623)
- Eppin and Fibronectin bind to each other in human semen and on human ejaculated spermatozoa. (PMID:24358212)
- eppin plays a role outside of the reproductive tract; eppin may have a role in the innate immune response in the lung (PMID:28705940)
Cross-species orthologs
16 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spint1b | ENSDARG00000012467 |
| danio_rerio | lrp11 | ENSDARG00000034076 |
| danio_rerio | wfikkn1 | ENSDARG00000101364 |
| danio_rerio | spint1a | ENSDARG00000102332 |
| mus_musculus | Eppin | ENSMUSG00000017733 |
| rattus_norvegicus | Eppin | ENSRNOG00000028908 |
| drosophila_melanogaster | CG7565 | FBGN0035833 |
| caenorhabditis_elegans | WBGENE00008304 | |
| caenorhabditis_elegans | WBGENE00008449 | |
| caenorhabditis_elegans | WBGENE00009386 | |
| caenorhabditis_elegans | WBGENE00010792 | |
| caenorhabditis_elegans | WBGENE00012186 | |
| caenorhabditis_elegans | WBGENE00012814 | |
| caenorhabditis_elegans | WBGENE00015355 | |
| caenorhabditis_elegans | WBGENE00020648 | |
| caenorhabditis_elegans | WBGENE00021939 |
Paralogs (13): TFPI (ENSG00000003436), TFPI2 (ENSG00000105825), AMBP (ENSG00000106927), LRP11 (ENSG00000120256), WFIKKN1 (ENSG00000127578), KIAA0319 (ENSG00000137261), KIAA0319L (ENSG00000142687), SPINT4 (ENSG00000149651), WFDC8 (ENSG00000158901), SPINT1 (ENSG00000166145), SPINT2 (ENSG00000167642), WFIKKN2 (ENSG00000173714), WFDC6 (ENSG00000243543)
Protein
Protein identifiers
Eppin — O95925 (reviewed: O95925)
Alternative names: Cancer/testis antigen 71, Epididymal protease inhibitor, Protease inhibitor WAP7, Serine protease inhibitor-like with Kunitz and WAP domains 1, WAP four-disulfide core domain protein 7
All UniProt accessions (3): O95925, A0A384NYB9, B7ZBA9
UniProt curated annotations — full annotation on UniProt →
Function. Serine protease inhibitor that plays an essential role in male reproduction and fertility. Modulates the hydrolysis of SEMG1 by KLK3/PSA (a serine protease), provides antimicrobial protection for spermatozoa in the ejaculate coagulum, and binds SEMG1 thereby inhibiting sperm motility.
Subunit / interactions. Monomer. Homodimer. Homomultimers. Interacts with SEMG1 (via 164-283 AA). Interacts with LTF. Found in a complex with LTF, CLU, EPPIN and SEMG1.
Subcellular location. Secreted. Cell surface.
Tissue specificity. In testis, expressed and secreted by Sertoli cells, appearing on the surface of testicular and ejaculate spermatozoa. Expressed in the spermatogonia and the earliest preleptotene spermatocytes. In the epididymis, is expressed and secreted by epithelial cells and covers the surface of epididymal spermatozoa and ciliated epithelial cells (at protein level). Expressed specifically in epididymis and testis. Isoform 2 is expressed only in the epididymis. Weak expression is detected in myoid cells as well as spermatogenic cells.
Domain organisation. The BPTI/Kunitz inhibitor domain is required for elastase inhibitory activity. BPTI/Kunitz inhibitor and WAP domains are involved in the protein antibacterial activity.
Miscellaneous. Might be used as a target for male contraception. Lacks a cleavable signal sequence. Based on a readthrough transcript which may produce a EPPIN-WFDC6 fusion protein.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O95925-1 | 1 | yes |
| O95925-2 | 2, Eppin-2 | |
| O95925-3 | 3 |
RefSeq proteins (2): NP_001289790, NP_065131* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002223 | Kunitz_BPTI | Domain |
| IPR008197 | WAP_dom | Domain |
| IPR020901 | Prtase_inh_Kunz-CS | Conserved_site |
| IPR036645 | Elafin-like_sf | Homologous_superfamily |
| IPR036880 | Kunitz_BPTI_sf | Homologous_superfamily |
| IPR051388 | Serpin_venom_toxin | Family |
Pfam: PF00014, PF00095
UniProt features (24 total): disulfide bond 7, mutagenesis site 7, splice variant 2, sequence variant 2, domain 2, region of interest 2, signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95925-F1 | 89.87 | 0.69 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (7): 77–127, 86–110, 102–123, 33–61, 40–65, 48–60, 54–69
Mutagenesis-validated functional residues (7):
| Position | Phenotype |
|---|---|
| 87 | loss of effect on klk3 activity. |
| 102 | reduces the binding to semg1 by 45%. |
| 107 | reduces the binding to semg1 by 68%. |
| 110 | does not affect the binding of semg1 or ltf. does not affect the binding of semg1; when associated with a-123 and a-127. |
| 117 | reduces the binding to semg1 by 68% and to ltf by 73%. |
| 123 | does not affect the binding of semg1 or ltf. does not affect the binding of semg1; when associated with a-110 and a-127. |
| 127 | does not affect the binding of semg1 or ltf. does not affect the binding of semg1; when associated with a-110 and a-123. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-6803157 | Antimicrobial peptides |
MSigDB gene sets: 116 (showing top):
GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP, GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS, GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS, GOCC_SECRETORY_GRANULE, GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY, GOCC_CELL_SURFACE, GOBP_MONOATOMIC_CATION_TRANSPORT, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, GOBP_REGULATION_OF_HYDROLASE_ACTIVITY, GOBP_NEGATIVE_REGULATION_OF_TRANSPORT, GOBP_CALCIUM_ION_IMPORT, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT
GO Biological Process (4): negative regulation of peptidase activity (GO:0010466), defense response to bacterium (GO:0042742), negative regulation of calcium ion import (GO:0090281), negative regulation of flagellated sperm motility (GO:1901318)
GO Molecular Function (3): serine-type endopeptidase inhibitor activity (GO:0004867), protein binding (GO:0005515), peptidase inhibitor activity (GO:0030414)
GO Cellular Component (7): acrosomal vesicle (GO:0001669), obsolete extracellular space (GO:0005615), cell surface (GO:0009986), protein-containing complex (GO:0032991), sperm plasma membrane (GO:0097524), extracellular region (GO:0005576), cytoplasm (GO:0005737)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Innate Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| peptidase activity | 2 |
| negative regulation of proteolysis | 1 |
| negative regulation of hydrolase activity | 1 |
| regulation of peptidase activity | 1 |
| defense response | 1 |
| response to bacterium | 1 |
| negative regulation of calcium ion transport | 1 |
| calcium ion import | 1 |
| regulation of calcium ion import | 1 |
| negative regulation of cilium movement | 1 |
| flagellated sperm motility | 1 |
| regulation of flagellated sperm motility | 1 |
| negative regulation of cilium-dependent cell motility | 1 |
| negative regulation of reproductive process | 1 |
| serine-type endopeptidase activity | 1 |
| endopeptidase inhibitor activity | 1 |
| binding | 1 |
| enzyme inhibitor activity | 1 |
| peptidase regulator activity | 1 |
| secretory granule | 1 |
| cellular_component | 1 |
| plasma membrane | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
864 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EPPIN | SEMG1 | P04279 | 755 |
| EPPIN | SPINT4 | Q6UDR6 | 717 |
| EPPIN | ETV4 | P43268 | 714 |
| EPPIN | WFDC10A | Q9H1F0 | 611 |
| EPPIN | GATA1 | P15976 | 548 |
| EPPIN | DEFB126 | Q9BYW3 | 541 |
| EPPIN | CT55 | Q8WUE5 | 506 |
| EPPIN | CPXCR1 | Q8N123 | 479 |
| EPPIN | KLK3 | P07288 | 479 |
| EPPIN | TULP2 | O00295 | 478 |
| EPPIN | WFDC3 | Q8IUB2 | 437 |
| EPPIN | WFDC9 | Q8NEX5 | 435 |
| EPPIN | CRISP2 | P16562 | 434 |
| EPPIN | JUN | P05412 | 411 |
| EPPIN | SEMG2 | Q02383 | 403 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| EPPIN | UMPS | psi-mi:“MI:0914”(association) | 0.530 |
| EPPIN | HSPA5 | psi-mi:“MI:0914”(association) | 0.350 |
| EPPIN | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): LTF (Co-fractionation), CLU (Co-fractionation), EPPIN (Affinity Capture-Western), LTF (Far Western), CLU (Far Western), UMPS (Affinity Capture-MS), HSPA5 (Affinity Capture-MS), UMPS (Affinity Capture-MS), ADAM9 (Affinity Capture-MS), EPPIN (Protein-RNA)
ESM2 similar proteins: A4K2P0, A5X2X1, A6MFL2, A7X3V4, A7X3V7, A7X4K1, A8Y7N4, A8Y7N7, A8Y7N8, A8Y7N9, A8Y7P5, B2BS84, B2KTG1, B5KF95, B5KF96, B5KL34, B5KL36, B5L5Q8, B7S4N9, D4A2Z2, E5AJX3, F6ULY1, H6VC05, I2G9B4, O35536, O43278, O43291, O95925, P00974, P00991, P00992, P01173, P01174, P04815, Q08E66, Q29100, Q2ES46, Q3UW55, Q4KUS1, Q6T6S5
Diamond homologs: A0A6P8HC43, A5X2X1, A6MFL4, A7X3V4, B2BS84, B2KTG1, B5G6G6, B5KF95, B5KF96, B5KL36, B5L5M7, B5L5R0, B6ZIW0, B7S4N9, C0HJU6, C0HLB2, C0HMC7, C1IC50, C1IC53, F6ULY1, F8J2F3, H2A0P0, O43291, O54819, O95925, P00974, P00976, P00978, P00993, P00994, P02760, P04365, P04366, P04815, P05067, P08592, P0C8W3, P0DN06, P0DN07, P0DN08
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
491 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:45542769:C:CT | acceptor_gain | 1.0000 |
| 20:45547263:TTA:T | donor_loss | 1.0000 |
| 20:45547264:TAC:T | donor_loss | 1.0000 |
| 20:45547265:A:AC | donor_gain | 1.0000 |
| 20:45547265:ACTGG:A | donor_loss | 1.0000 |
| 20:45547266:C:CG | donor_gain | 1.0000 |
| 20:45547266:C:CT | donor_gain | 1.0000 |
| 20:45547266:CT:C | donor_gain | 1.0000 |
| 20:45547266:CTG:C | donor_gain | 1.0000 |
| 20:45547266:CTGG:C | donor_gain | 1.0000 |
| 20:45547266:CTGGG:C | donor_gain | 1.0000 |
| 20:45547261:ACTT:A | donor_loss | 0.9900 |
| 20:45547262:CTTA:C | donor_gain | 0.9900 |
| 20:45541386:G:C | acceptor_gain | 0.9800 |
| 20:45546402:T:TC | acceptor_gain | 0.9800 |
| 20:45547296:C:A | donor_gain | 0.9700 |
| 20:45545633:TATTA:T | donor_loss | 0.9600 |
| 20:45545634:ATTAC:A | donor_loss | 0.9600 |
| 20:45545635:TTACC:T | donor_loss | 0.9600 |
| 20:45545636:TACCT:T | donor_loss | 0.9600 |
| 20:45545637:ACC:A | donor_loss | 0.9600 |
| 20:45545637:ACCTT:A | donor_loss | 0.9600 |
| 20:45545638:C:A | donor_loss | 0.9600 |
| 20:45545769:CC:C | acceptor_gain | 0.9600 |
| 20:45545770:CC:C | acceptor_gain | 0.9600 |
| 20:45547261:A:AC | donor_gain | 0.9600 |
| 20:45547262:C:CC | donor_gain | 0.9600 |
| 20:45542814:A:T | acceptor_gain | 0.9500 |
| 20:45545687:T:TA | donor_gain | 0.9500 |
| 20:45545767:CTCC:C | acceptor_gain | 0.9500 |
AlphaMissense
889 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:45542776:A:C | F105L | 0.973 |
| 20:45542776:A:T | F105L | 0.973 |
| 20:45542778:A:G | F105L | 0.973 |
| 20:45542740:G:C | F117L | 0.972 |
| 20:45542740:G:T | F117L | 0.972 |
| 20:45542742:A:G | F117L | 0.972 |
| 20:45542777:A:C | F105C | 0.963 |
| 20:45542741:A:C | F117C | 0.954 |
| 20:45545673:G:C | F63L | 0.951 |
| 20:45545673:G:T | F63L | 0.951 |
| 20:45545675:A:G | F63L | 0.951 |
| 20:45545674:A:C | F63C | 0.930 |
| 20:45542762:C:G | C110S | 0.922 |
| 20:45542763:A:T | C110S | 0.922 |
| 20:45542723:C:G | C123S | 0.905 |
| 20:45542724:A:T | C123S | 0.905 |
| 20:45542861:C:G | C77S | 0.905 |
| 20:45542862:A:T | C77S | 0.905 |
| 20:45545656:C:G | C69S | 0.903 |
| 20:45545657:A:T | C69S | 0.903 |
| 20:45545719:C:G | C48S | 0.902 |
| 20:45545720:A:T | C48S | 0.902 |
| 20:45542741:A:G | F117S | 0.901 |
| 20:45545701:C:G | C54S | 0.901 |
| 20:45545702:A:T | C54S | 0.901 |
| 20:45542747:T:A | N115I | 0.893 |
| 20:45542786:C:G | C102S | 0.889 |
| 20:45542787:A:T | C102S | 0.889 |
| 20:45542834:C:G | C86S | 0.886 |
| 20:45542835:A:T | C86S | 0.886 |
dbSNP variants (sampled 300 via entrez): RS1000113555 (20:45542069 C>T), RS1000310170 (20:45546404 G>T), RS1000312325 (20:45547619 G>A,T), RS1000429870 (20:45546738 A>G), RS1001416692 (20:45541372 A>G), RS1001947251 (20:45547171 T>A,C), RS1002336740 (20:45546077 G>C), RS1002953006 (20:45543679 T>G), RS1003013862 (20:45548699 T>C), RS1003310675 (20:45545089 GTAT>G), RS1003710659 (20:45542646 G>C), RS1003824274 (20:45546290 G>T), RS1004553631 (20:45544159 G>A), RS1004985522 (20:45545812 A>C,G), RS1005820510 (20:45545582 G>A)
Disease associations
OMIM: gene MIM:609031 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | increases reaction, affects binding | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation, increases methylation | 1 |
| Dimethyl Sulfoxide | affects expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Cadmium Chloride | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.